Dr Heidi Hilton

Research Fellow
Medicine, Westmead Clinical School
The Westmead Institute for Medical Research

Cancer research network

Telephone 02 8627 3703

Website Honours in Medical Sciences at Westmead

Map

Selected grants

2016

  • Generation and use of novel model systems to study steroid hormone action in the breast; Hilton H; Cancer Australia/Priority Driven Collaborative Cancer Research Scheme.
  • Generation and use of novel model systems to study steroid hormone action in the breast; Hilton H; Cancer Council New South Wales/Research Project Grants.
  • Targeting the progesterone signalling axis for breast cancer treatment and prevention; Hilton H; National Breast Cancer Foundation/Career Development Fellowship.

2015

  • Acquired convergence of steroid hormone signaling in breast cancer; Hilton H; DVC Research/Bridging Support Grant.
  • Role of progesterone in normal breast and its convergence with estrogen action in breast cancer; Clarke C, Ormandy C, Graham J, Hilton H; Cancer Council New South Wales/Research Project Grants.

2014

  • Gordon Research Conference 7 June 2014 - Mammary Gland Biology; Hilton H; CASS Foundation Limited/Travel Support.

2012

  • Cell type specificity of progesterone action in the normal human breast and in breast cancer; Hilton H; National Breast Cancer Foundation/Postdoctoral Fellowship.
  • CureCncerAusFdn Co-fund; Hilton H; Cure Cancer Australia Foundation/Research Support.

2011

  • The impact of aberrant progesterone signalling on lineage specification during early malignant transformation; Hilton H; Cancer Australia/Priority Driven Collaborative Cancer Research Scheme.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Hilton, H., Graham, J., Clarke, C. (2012). Estrogen and Progestin Stimulation of Breast Proliferation. In R. Paul Robinson (Eds.), Translational Endocrinology & Metabolism: Breast Cancer Update, (pp. 1-28). Maryland, United States: The Endocrine Society.

Journals

  • Hilton, H., Clarke, C. (2015). Impact of Progesterone on Stem/Progenitor Cells in the Human Breast. Journal of Mammary Gland Biology and Neoplasia, 20(1-2), 27-37. [More Information]
  • Hilton, H., Graham, J., Clarke, C. (2015). Minireview: Progesterone Regulation of Proliferation in the Normal Human Breast and in Breast Cancer: A Tale of Two Scenarios? Molecular Endocrinology, 29(9), 1230-1242. [More Information]
  • Clarke, C., Dontu, G., Hilton, H., Meier-Abt, F., Sartorius, C. (2015). Preface. Journal of Mammary Gland Biology and Neoplasia, 20(1-2), 5-7. [More Information]
  • Mote, P., Gompell, A., Howe, C., Hilton, H., Sestak, I., Cuzick, J., Dowsett, M., Hugol, D., Forgez, P., Byth Wilson, K., Graham, J., Clarke, C. (2015). Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trial. Breast Cancer Research and Treatment, 151(2), 309-318. [More Information]
  • Hilton, H., Doan, T., Graham, J., Oakes, S., Silvestri, A., Santucci, N., Kantimm, S., Huschtscha, L., Ormandy, C., Funder, J., Kuczek, E., Clarke, C., et al (2014). Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease. Oncotarget, 5(18), 8651-8664.
  • Hilton, H., Santucci, N., Silvestri, A., Kantimm, S., Huschtscha, L., Graham, J., Clarke, C. (2014). Progesterone stimulates progenitor cells in normal human breast and breast cancer cells. Breast Cancer Research and Treatment, 143(3), 423-433.
  • Hilton, H., Graham, J. (2014). The molecular landscape of the normal human breast- defining normal. Breast Cancer Research, 16(3), 1-3. [More Information]
  • Hilton, H., Kantimm, S., Graham, J., Clarke, C. (2013). Changed lineage composition is an early event in breast carcinogenesis. Histology and histopathology, 28(9), 1197-1204. [More Information]
  • Hilton, H., Graham, J., Kantimm, S., Santucci, N., Cloosterman, D., Huschtscha, L., Mote, P., Clarke, C. (2012). Progesterone and estrogen receptors segregate into different cell subpopulations in the normal human breast. Molecular And Cellular Endocrinology, 361(1-2), 191-201. [More Information]
  • Hilton, H., Kalyuga, M., Cowley, M., Alles, M., Lee, H., Caldon, C., Blazek, K., Kaplan, W., Musgrove, E., Daly, R., Graham, J., Clarke, C., et al (2010). The Antiproliferative Effects of Progestins in T47D Breast Cancer Cells Are Tempered by Progestin Induction of the ETS Transcription Factor Elf5. Molecular Endocrinology, 24(7), 1380-1392. [More Information]
  • Hilton, H., Stanford, P., Harris, J., Oakes, S., Kaplan, W., Daly, R., Ormandy, C. (2008). KIBRA interacts with discoidin domain receptor 1 to modulate collagen-induced signalling. Biochimica et Biophysica Acta. Molecular and Cell Biology of Lipids, 1783 (3), 383-393. [More Information]
  • Oakes, S., Naylor, M., Asselin-Labat, M., Blazek, K., Gardiner-Garden, M., Hilton, H., Kazlauskas, M., Pritchard, M., Chodosh, L., Pfeffer, P., et al (2008). The Ets transcription factor Elf5 specifies mammary alveolar cell fate. Genes and Development, 22(5), 581-586. [More Information]
  • Oakes, S., Hilton, H., Ormandy, C. (2006). Key stages in mammary gland development: The alveolar switch: coordinating the proliferative cues and cell fate decisions that drive the formation of lobuloalveoli from ductal epithelium. Breast Cancer Research, 8(2), 207. [More Information]
  • Harris, J., Stanford, P., Sutherland, K., Oakes, S., Naylor, M., Robertson, F., Blazek, K., Kazlauskas, M., Hilton, H., Wittlin, S., et al (2006). Socs2 and elf5 mediate prolactin-induced mammary gland development. Molecular Endocrinology, 20(5), 1177-1187. [More Information]

2015

  • Hilton, H., Clarke, C. (2015). Impact of Progesterone on Stem/Progenitor Cells in the Human Breast. Journal of Mammary Gland Biology and Neoplasia, 20(1-2), 27-37. [More Information]
  • Hilton, H., Graham, J., Clarke, C. (2015). Minireview: Progesterone Regulation of Proliferation in the Normal Human Breast and in Breast Cancer: A Tale of Two Scenarios? Molecular Endocrinology, 29(9), 1230-1242. [More Information]
  • Clarke, C., Dontu, G., Hilton, H., Meier-Abt, F., Sartorius, C. (2015). Preface. Journal of Mammary Gland Biology and Neoplasia, 20(1-2), 5-7. [More Information]
  • Mote, P., Gompell, A., Howe, C., Hilton, H., Sestak, I., Cuzick, J., Dowsett, M., Hugol, D., Forgez, P., Byth Wilson, K., Graham, J., Clarke, C. (2015). Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trial. Breast Cancer Research and Treatment, 151(2), 309-318. [More Information]

2014

  • Hilton, H., Doan, T., Graham, J., Oakes, S., Silvestri, A., Santucci, N., Kantimm, S., Huschtscha, L., Ormandy, C., Funder, J., Kuczek, E., Clarke, C., et al (2014). Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease. Oncotarget, 5(18), 8651-8664.
  • Hilton, H., Santucci, N., Silvestri, A., Kantimm, S., Huschtscha, L., Graham, J., Clarke, C. (2014). Progesterone stimulates progenitor cells in normal human breast and breast cancer cells. Breast Cancer Research and Treatment, 143(3), 423-433.
  • Hilton, H., Graham, J. (2014). The molecular landscape of the normal human breast- defining normal. Breast Cancer Research, 16(3), 1-3. [More Information]

2013

  • Hilton, H., Kantimm, S., Graham, J., Clarke, C. (2013). Changed lineage composition is an early event in breast carcinogenesis. Histology and histopathology, 28(9), 1197-1204. [More Information]

2012

  • Hilton, H., Graham, J., Clarke, C. (2012). Estrogen and Progestin Stimulation of Breast Proliferation. In R. Paul Robinson (Eds.), Translational Endocrinology & Metabolism: Breast Cancer Update, (pp. 1-28). Maryland, United States: The Endocrine Society.
  • Hilton, H., Graham, J., Kantimm, S., Santucci, N., Cloosterman, D., Huschtscha, L., Mote, P., Clarke, C. (2012). Progesterone and estrogen receptors segregate into different cell subpopulations in the normal human breast. Molecular And Cellular Endocrinology, 361(1-2), 191-201. [More Information]

2010

  • Hilton, H., Kalyuga, M., Cowley, M., Alles, M., Lee, H., Caldon, C., Blazek, K., Kaplan, W., Musgrove, E., Daly, R., Graham, J., Clarke, C., et al (2010). The Antiproliferative Effects of Progestins in T47D Breast Cancer Cells Are Tempered by Progestin Induction of the ETS Transcription Factor Elf5. Molecular Endocrinology, 24(7), 1380-1392. [More Information]

2008

  • Hilton, H., Stanford, P., Harris, J., Oakes, S., Kaplan, W., Daly, R., Ormandy, C. (2008). KIBRA interacts with discoidin domain receptor 1 to modulate collagen-induced signalling. Biochimica et Biophysica Acta. Molecular and Cell Biology of Lipids, 1783 (3), 383-393. [More Information]
  • Oakes, S., Naylor, M., Asselin-Labat, M., Blazek, K., Gardiner-Garden, M., Hilton, H., Kazlauskas, M., Pritchard, M., Chodosh, L., Pfeffer, P., et al (2008). The Ets transcription factor Elf5 specifies mammary alveolar cell fate. Genes and Development, 22(5), 581-586. [More Information]

2006

  • Oakes, S., Hilton, H., Ormandy, C. (2006). Key stages in mammary gland development: The alveolar switch: coordinating the proliferative cues and cell fate decisions that drive the formation of lobuloalveoli from ductal epithelium. Breast Cancer Research, 8(2), 207. [More Information]
  • Harris, J., Stanford, P., Sutherland, K., Oakes, S., Naylor, M., Robertson, F., Blazek, K., Kazlauskas, M., Hilton, H., Wittlin, S., et al (2006). Socs2 and elf5 mediate prolactin-induced mammary gland development. Molecular Endocrinology, 20(5), 1177-1187. [More Information]

To update your profile click here. For support on your academic profile contact .